Published in
Taylor and Francis Group, Expert Opinion on Therapeutic Targets, 10(21), p. 949-958, 2017
DOI: 10.1080/14728222.2017.1369960
Links
Tools
Agrin-LRP4-MuSK signaling as a therapeutic target for myasthenia gravis and other neuromuscular disorders
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 